Primary results of rucaparib in ovarian cancer
- 5 August 2022
- conference paper
- conference paper
- Published by Medicom Medische Uitgeverij BV in Medicom Conference Report ASCO 2022
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian CancerThe New England Journal of Medicine, 2018
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet, 2017